RT Journal Article
SR Electronic
T1 A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
JF BMJ Open
JO BMJ Open
FD British Medical Journal Publishing Group
SP e002971
DO 10.1136/bmjopen-2013-002971
VO 3
IS 7
A1 Yutaka Usui
A1 Akiko Kaga
A1 Fumikazu Sakai
A1 Ayako Shiono
A1 Ken-ichiro Komiyama
A1 Koichi Hagiwara
A1 Minoru Kanazawa
YR 2013
UL http://bmjopen.bmj.com/content/3/7/e002971.abstract
AB Objectives To assess clinical, laboratory and radiographic findings associated with outcomes and to clarify more practical ways to predict hospital mortality in patients with acute exacerbation (AE) of chronic fibrosing interstitial pneumonia (CFIP). Design Single-centre retrospective cohort study. Setting University Hospital in Japan. Participants We identified 51 consecutive patients with AE of idiopathic CFIP through multidisciplinary discussion. Patients who had connective tissue disease, drug-induced lung disease, pneumoconiosis, hypersensitivity pneumonitis, sarcoidosis, pulmonary histiocytosis, lymphangioleiomyomatosis and eosinophilic pneumonia were excluded. Interventions There were no interventions. Main outcome measures The main outcome was determination of in-hospital mortality predictors. Other outcomes included clinical, laboratory and radiographic differences between non-survivors and survivors in patients with AE of CFIP. Results The mean age of the patients with AE of CFIP was 71 years. Compared with survivors, non-survivors had a significantly shorter duration of symptoms before admission, lower prevalence of peripheral distribution of ground-glass opacity and centrilobular emphysema (CLE) on thin-section CT, lower peripheral lymphocyte count, higher brain natriuretic peptide titre, lower Pao2:Fio2 (P:F) ratio, higher prevalence of systemic inflammatory response syndrome (SIRS) and higher SIRS score on admission (p=0.0069, 0.0032, 0.015, 0.040, 0.0098, 0.012, 9.9×10−7 and 5.4×10−6, respectively). Multivariate analysis revealed SIRS (HR=6.2810, p=0.015), CLE (HR=0.0606, p=3.6×10−5) and serum procalcitonin level (HR=2.7110, p=0.022) to be independent predictors of in-hospital mortality. A Kaplan-Meier estimate on the basis of stratification according to the presence or absence of SIRS and CLE demonstrated a distinct survival curve for each subset of patients. Conclusions Distinct survival curves documented by stratification according to the presence or absence of SIRS and CLE may provide basic information for a rational management strategy for patients with AE of CFIP on admission.